Pharmacogenetics of Alcohol Use Disorders Joseph P. Schacht, Ph.D. Department of Psychiatry & Behavioral Sciences Medical University of South Carolina.

Slides:



Advertisements
Similar presentations
Drugs used in the Treatment of Alcohol Abuse/Addiction Tristan Knowles.
Advertisements

The Addicted Synapse Katie Malanson.
OPTION E E4 NEUROTRANSMITTERS AND SYNAPSES
Motivations for Alcohol Use Evan Goulding, MD, PhD Department of Psychiatry and Behavioral Sciences Feinberg School of Medicine Northwestern University.
Evidence-Based Guidelines for Pharmacotherapy in Alcohol Dependence Chandan Nayak, MD Addiction Fellow University of Michigan Department of Psychiatry.
Copyright Alcohol Medical Scholars Program1 Substance Use Disorders: Does Treatment Work? Christina M. Delos Reyes, MD Department of Psychiatry CWRU School.
Drugs used in the Treatment of Alcohol Abuse/Addiction Tristan Knowles.
Copyright Alcohol Medical Scholars Program 1 Integrated Treatment of Co-Occurring Mental Illness (MI) and Substance Use Disorders (SUD) Krishna Balachandra,
1 Impaired Decision Making In Substance Use Disorders Claire Wilcox MD UNM Dept of Psychiatry Alcohol Medical Scholars Program © AMSP.
What is Mendelian Randomisation? Frank Dudbridge.
Disease X in 1985 No Data
Social Anxiety Disorder and Alcoholism Sarah W. Book MD Medical University of South Carolina.
Bipolar Disorder and Alcohol Use Disorders Marcy Verduin, M.D. University of Central Florida 1 © AMSP 2010.
An Integrative Approach to Psychopathology
Pharmacotherapy for Alcohol Dependence Clinical Addiction Research and Education Unit Section of General Internal Medicine Boston University Schools of.
Substance-Use Disorders Lori Ridgeway PSYC What is abuse? Criteria Failure to meet responsibilities Use despite potential dangers Legal problems.
Genetic Testing in Genomic Medicine Gail H. Vance M.D. Professor, Department of Medical & Molecular Genetics Indiana University School of Medicine.
Recreational Therapy: An Introduction Chapter 5: Substance Use Disorders PowerPoint Slides.
Genetics & Addiction Jonathan D. Pollock, Ph.D. Division of Neuroscience & Behavioral Research National Institute on Drug Abuse National Institutes of.
Alcohol & other addictions: can DNA make a difference? Dr Martin Kennedy Department of Pathology Christchurch School of Medicine & Health Sciences University.
Prevalence of Alcohol Use Disorders
Copyright Alcohol Medical Scholars Program1 Alcohol: Pharmacology and Neurobiology Vijay A. Ramchandani, Ph.D. Indiana University School of Medicine.
Copyright Alcohol Medical Scholars Program1 Pathological Gambling and Alcohol Use Disorders Timothy W. Fong MD UCLA Gambling Studies Program Alcohol Medical.
Role of Medications in Recovery and the Prevention of Relapse Mark Publicker, MD FASAM Medical Director, Mercy Recovery Center, Westbrook Maine.
AN OVERVIEW OF GENETIC INFLUENCES IN ALCOHOLISM Marc A. Schuckit.
Copyright Alcohol Medical Scholars Program1 The Relationships Between Alcohol Use Disorders and Nicotine Dependence Margaret Rukstalis, M.D. University.
Causes and Treatment of Substance Use Disorders Chapter 11.
Chapter 18 Psychoactive Substance Use Disorders: Drugs.
Substance-Related and Impulse-Control Disorders
Substance Use Disorders in Adolescence Chapter 15 Sandra A. Brown, Kristin Tomlinson, and Jennifer Winward.
Impulsivity and Alcohol Use Disorders Robert F. Leeman, Ph.D. Department of Psychiatry Yale School of Medicine VA (New England) VISN1 Mental Illness Research.
Copyright © 2007 by The McGraw-Hill Companies, Inc. All rights reserved. Chapter 17 Substance-Related Disorders – Focus on Alcoholism.
Chapter 9 Alcohol Acute effects Mechanisms of action Long-term effects
Alcohol training Dr Akwasi Osei Consultant Psychiatrist Ag. Chief Psychiatrist - GHS 23 April 2009 Addiction as a disease.
Alcohol and Other Drugs
Introduction: Medical Psychology and Border Areas
Substitutes for the Thumb The thumb is our original coping device- we use it to self-soothe. The chemistry of contentment.
GENES and TOBACCO USE. CAN GENES PREDICT WHO WILL… develop heart disease? develop lung cancer? become a smoker? be able to quit?
Case Study#2: Effect of Alcohol/Drugs on Teen Brain Yehuda Ben-Shahar, PhD Department of Biology, Washington University in St. Louis.
Copyright © 2009 Pearson Education, Inc. publishing as Benjamin Cummings Lectures by Greg Podgorski, Utah State University Alcoholism and Our Genes Scientific.
Substance Use Disorders. A maladaptive pattern of substance use leading to clinically significant social, emotional, or occupational impairment or distress.
Recent Developments in the Pharmacotherapy of Alcoholism Henry R. Kranzler, M.D. Alcohol Research Center Univ. of CT School of Medicine.
  Site: faculty.ksu.edu.sa/10252.
Evidence Based Medicine Pharmacological Treatment of Alcohol Dependence.
THIS LECTURE REVIEWS RISK FOR ALCOHOLISM SENSITIVITY (LR) AS RISK GENES & ENVIRONMENT RECENT DEVELOPMENTS.
Pharmacotherapy for Alcohol Dependence
Drug abuse and addiction. objectives Analyze substance abuse and give 2 symptoms of the disorder Compare and contrast the models of addiction (biological.
Alcoholism in Finland By Simon Kaklugin and Johanna Lehtinen.
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
Better Health. No Hassles. ALCOHOLISM Chronic disease that makes your body dependent on alcohol. Unable to control how much you drink !! Causing problems.
Challenges to drug design Did you know? Over 2 million people are hospitalized each year for adverse reactions to prescription drugs. Over 2 million.
Neurotransmissions in the Central Nervous System.
Lesson 14: Heritability learn about the methods for studying traits to determine if genes influence them; specifically learn about how to analyze data.
ALDH2 and Conduct Disorder Mediate Ethnicity and Alcohol Dependence in Chinese-, Korean-, and White-American College Students S.E. Luczak, T.A.R. Cook,
Targeted medication 은 가능한가 ? 알코올 사용장애 환자의 치료 전략으로 건양대학병원 정신과 기 선 완.
Alcohol Use and Suicidal Behavior in College Students Dorian A. Lamis, PhD Department of Psychiatry & Behavioral Sciences Emory University School of Medicine.
The Science of Addiction. Homelessness Crime Violence Homelessness Crime Violence Neurotoxicity AIDS, Cancer Mental illness Neurotoxicity AIDS, Cancer.
December 10, 2015 Arthur Robin Williams MD MBE American Academy of Addiction Psychiatry Division on Substance Abuse Department of Psychiatry, Columbia.
Considering Genetics/Heredity
C-Notes: Alcoholism Stnd: 1.10 A 04/04/14 Objective:
I. Considering Genetics/Heredity
Course of Alcohol Use Disorders: Data from a 35 Year Follow Up
Chapter 38 Drug Abuse II: Alcohol 1.
Treatment Professionals Conference
Genetic explanations of addiction
Alcohol.
Pharmacologic Interventions for Unhealthy Drinking
Neurotransmitters and the Synapse
Medications used in Treatment of Alcohol and Drug Use Disorders
Gender Issues and Addiction
Presentation transcript:

Pharmacogenetics of Alcohol Use Disorders Joseph P. Schacht, Ph.D. Department of Psychiatry & Behavioral Sciences Medical University of South Carolina

Alcohol Use Disorders (AUDs) Severe problems with alcohol Lifetime risk for men = ~15%; for women = ~10% Decrease lifespan by ~10 years Rx is challenging – High relapse rates – Few empirically supported Rx’s Strong genetic basis – Genes may predict risk – Genes may predict Rx response © Alcohol Medical Scholars Program2

Lecture Covers Some definitions How genes affect AUD risk Key elements of AUD Rx Roles of medications in Rx How genes relate to Rx response © Alcohol Medical Scholars Program3

Lecture Covers Some definitions How genes affect AUD risk Key elements of AUD Rx Roles of medications in Rx How genes relate to Rx response © Alcohol Medical Scholars Program4

Definition of AUDs Result of many years heavy alcohol use Causes impairment or distress Impact across multiple aspects of life DSM-5: ≥ 2 criteria, past 12 mo. © Alcohol Medical Scholars Program5

AUD Diagnostic Criteria – ↑ Amount/time spent drinking – ↑ Time obtain/use/recover – Failure to fulfill life obligations – Giving up important activities – Drinking despite social problems – Drinking despite health problems © Alcohol Medical Scholars Program6 – Desire/inability to ↓/stop – Craving – Hazardous use – Tolerance – Withdrawal

Genetics Primer Every cell in body carries DNA – Holds genetic info (genes) for organism – Double-stranded: 2 copies (“alleles”) each gene – Inherit one allele from each parent Mutation = random change in gene – Can produce new traits – Can inherit 0, 1, or 2 copies of mutation – If 1 copy, might have trait; if 2, will have it © Alcohol Medical Scholars Program7

Lecture Covers Some definitions How genes affect AUD risk Key elements of AUD Rx Roles of medications in Rx How genes relate to Rx response © Alcohol Medical Scholars Program8

Genetics of AUDs AUDs are ~60% genes, 40% environment: – Children of alcoholics have 4x ↑ AUD risk – Risk ↑ with closer genetic relationship – Same ↑ risk if adopted & raised in non-AUD family – Identical twin of AUD person > risk vs fraternal twin © Alcohol Medical Scholars Program9

Genes that Affect AUD Risk Example #1: Alcohol metabolizing enzymes Alcohol dehydrogenase (ADH) – Takes ethanol → acetaldehyde (ACH) – Mutation (ADH1B) works faster – → Slight ↑ ACH – → Small ↓ heavy drinking and AUD risk © Alcohol Medical Scholars Program10

Genes that Affect AUD Risk Example #1: Alcohol metabolizing enzymes Aldehyde dehydrogenase (ALDH) – Takes ACH → CO 2 + H 2 0 (acetic acid) – Mutation (ALDH2*2) → ↓ ACH metabolism – If both DNA strands have mutation → ↑ ill if drink – One strand → flush skin; not ill – These → ↓ heavy drinking and AUD risk ADH1B, ALDH2 variants both ↑ prevalence in Japanese, Chinese, Koreans © Alcohol Medical Scholars Program11

Genes that Affect AUD Risk Ex. #2: γ-aminobutyric acid (GABA) receptors GABA is major inhibitory neurotransmitter – Alcohol → ↑ GABA effects; causes sedation – Partly via GABA receptor α2 subunit (GABRA2) – Mutation may Δ receptor function,↓ inhibition – → ↑ alcohol effects and AUD risk © Alcohol Medical Scholars Program12

Ex. #2: γ-aminobutyric acid (GABA) receptors GABRA2 could contribute to ↑ impulsivity Also tied to childhood conduct Dx – Onset by age 10 – Act w/o thinking (impulsive) – Punishment does not always → change in behavior – ↑ likely to drink; ↓ learn from mistakes © Alcohol Medical Scholars Program13 Genes that Affect AUD Risk

Knowing AUD genes → little effect on Rx Most genes have small effects on AUD risk Too many genes to predict AUD risk individually Rx’s for ADH, ALDH, GABA don’t always work Newer data: genes may predict who benefits © Alcohol Medical Scholars Program14

Lecture Covers Some definitions How genes affect AUD risk Key elements of AUD Rx Roles of medications in Rx How genes relate to Rx response © Alcohol Medical Scholars Program15

Key Elements of AUD Rx Psychotherapy – Cognitive behavioral therapy – Relapse prevention Medications Peer support groups – Alcoholics Anonymous – AlAnon © Alcohol Medical Scholars Program16

Cognitive behavioral therapy (CBT) ID & correct problematic thoughts, behaviors Explore +/- drinking consequences Learn to ID craving quickly to avoid drinking Relapse prevention – ID & avoid high-risk situations – ↑ Effective non-drinking coping skills – ↑ Pt’s belief that he/she can change © Alcohol Medical Scholars Program17

Lecture Covers Some definitions How genes affect AUD risk Key elements of AUD Rx Roles of medications in Rx How genes relate to Rx response © Alcohol Medical Scholars Program18

Key Elements of AUD Rx Medications—4 main types: – Aversive (make you sick) – Anti-craving – Anti-convulsants – Serotonin-acting drugs © Alcohol Medical Scholars Program19

Aversive Medications Inhibit ALDH, cause ACH ↑ → Flushing, headache, nausea with alcohol Example: disulfiram (Antabuse) FDA-approved for AUD Rx © Alcohol Medical Scholars Program20

Anti-Craving Medications Inhibit dopamine release by alcohol ↓ Pleasurable effects of alcohol ↓ Craving & urge to drink Example: naltrexone (Revia) Injectable long-acting naltrexone: Vivitrol FDA-approved for AUD Rx © Alcohol Medical Scholars Program21

Anti-Convulsants ↑ GABA, ↓ glutamate (excitatory) ↓ Initial withdrawal sx (e.g., tremor, nausea) ↓ Longer-term withdrawal sx (e.g., ↑ HR) May help maintain abstinence Example: topiramate (Topamax) FDA-approved for epilepsy, chronic pain; off-label for AUD © Alcohol Medical Scholars Program22

Serotonin-Acting Drugs May be most effective in pts w/ early drinking May ↓ alcohol craving Example: ondansetron (Zofran) FDA-approved for nausea; off-label for AUD © Alcohol Medical Scholars Program23

Limitations of Medications These meds ↓ relapse, but effects are small Knowing pt’s genetic make-up might help – Could help to select med for specific pts – AUD is genetically influenced – Systems meds act on are genetically influenced © Alcohol Medical Scholars Program24

Lecture Covers Some definitions How genes affect AUD risk Key elements of AUD Rx Roles of medications in Rx How genes relate to Rx response © Alcohol Medical Scholars Program25

26 Image: New York Academy of Sciences

Intro to Pharmacogenetics Genetic differences affect responses to Rx Many examples for other conditions Example 1: Rx for thrombosis (blood clots) – Standard of care: warfarin (Coumadin) – But warfarin blood levels need be in narrow range – Med-metabolizing enzyme genes affect range – Use genes to predict ideal dose for individual pts © Alcohol Medical Scholars Program27

Intro to Pharmacogenetics Genetic differences affect responses to Rx Example 2: Cancer chemotherapy – Specific genetic mutations affect some tumors – Mutation → cellular growth pathway gone wild – Can target Rx to that specific pathway ↑ Likelihood affects tumor growth ↓ Likelihood of broad cell toxicity and side effects © Alcohol Medical Scholars Program28

Intro to Pharmacogenetics Genetic differences can affect: – Therapeutic effect: likelihood of benefit from med – Adverse effects: side effects Differences in AUD genes could affect response Or differences in genes related to med’s mechanism could affect response © Alcohol Medical Scholars Program29

Recent AUD Pharmacogenetic Findings Naltrexone and mu opioid receptor (OPRM1) – Naltrexone blocks brain OPRM1 – OPRM1 → ↑ dopamine, ↑ pleasure – Variant in gene → ↑ receptor function Present in ~25% of European-Americans More common (~40%) among Asian-Americans Rare (< 5%) among African-Americans – Variant associated w/ ↑ alcohol effects, craving © Alcohol Medical Scholars Program30

Naltrexone and OPRM1 Variant may predict ↑ naltrexone response – Original study: W/o variant: ~50% relapsed after 3 months W/ variant: ~25% relapsed after 3 months © Alcohol Medical Scholars Program31 Oslin et al., 2003

Naltrexone and OPRM1 Variant may predict ↑ naltrexone response – Large follow-up study: W/o variant: ~55% good clinical response W/ variant: ~90% good clinical response – But also negative studies © Alcohol Medical Scholars Program32 Anton et al., 2008

Topiramate and glutamate kainate (GRIK1) – Topiramate reduces excitatory neurotransmission – Primary excitatory neurotransmitter: glutamate – Variant in gene for one type of glutamate receptor: GRIK1 Associated w/ AUD risk Present in ~35% of European-Americans Less common (~20%) among Asian-Americans Rare (< 5%) among African-Americans © Alcohol Medical Scholars Program33 Recent AUD Pharmacogenetic Findings

Topiramate and GRIK1 Variant may predict ↓ topiramate side effects – Topiramate can have significant side effects Common (>10%): “pins & needles”, slowed thoughts Pts esp. dislike memory, word-finding difficulties – W/o variant: side effect severity = ~4 – W/variant: side effect severity = ~1 © Alcohol Medical Scholars Program34 Ray et al., 2009

Topiramate and GRIK1 Variant may also predict ↑ topiramate response – W/o variant: 1-2 heavy drinking days/week – W/ variant: ~1 heavy drinking day/week Result needs to be replicated © Alcohol Medical Scholars Program35 Kranzler et al., 2014

Serotonin-acting drugs and transporter (SLC6A4) – Ondansetron blocks serotonin receptor – Transporter (SERT) removes serotonin from synapse – Variant in gene for SERT (SLC6A4) ↓ SERT availability (so ↑ serotonin) Need variant on both DNA strands for beneficial effect Present in ~25% of European and African-Americans © Alcohol Medical Scholars Program36 Recent AUD Pharmacogenetic Findings

Ondansetron and SLC6A4 Variant may predict ↑ ondansetron response – W/o variant: ~12 percentage point ↑ in % days abstinent – W/ variant: ~22 percentage point ↑ in % days abstinent Result needs to be replicated © Alcohol Medical Scholars Program37 Johnson et al., 2011

Future Directions ↑ DNA collection in clinical trials Standardize outcomes – Good response, heavy drinking, % days abstinent – Issue for all AUD clinical trials! Prospective genotyping & randomization – Especially for rare variants – ↑ Likelihood that findings not by chance © Alcohol Medical Scholars Program38

Do genes affect psychosocial Rx response? Identify new genes that may affect Rx response – Especially for new meds – Identify genes that affect African-American Rx response Ultimate goal: personalized medicine approach – Don’t waste time on Rx that isn’t likely to work – Target Rx to pts most likely to benefit from it © Alcohol Medical Scholars Program39 Future Directions